NOV Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Novo Nordisk A/S

Watchlist Manager

Watchlist

Price: 42.11 EUR 0.33%

Market Cap: €140.6B

N	Novo Nordisk A/S XHAM:NOV	DK
	Rhoen Klinikum AG F:RHKU	DE
B	British American Tobacco PLC SWB:BMTA	UK
F	flatexDEGIRO AG DUS:FTK	DE
M	Meta Platforms Inc XBER:FB2A	US
S	Salesforce Inc F:FOO	US

Profitability Summary

Novo Nordisk A/S's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

81%

Strong 3Y Average Gross Margin

84%

Declining Gross Margin

84% > 81%

Exceptional Operating Margin

41%

Strong 3Y Average Operating Margin

44%

Declining Operating Margin

43% > 41%

Exceptional Net Margin

33%

Strong 3Y Average Net Margin

35%

Net Margin is Increasing

32% > 33%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

24%

Declining Free Cash Flow Margin

36% > 9%

Exceptional ROE

61%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

33%

Declining ROIC

34% > 22%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.